Drug recall D-0727-2026
Product
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
Reason for recall
Presence of Particulate Matter: Hair was found in products
Lots and codes
Lot #: 6133436, Exp. Date 10/2028
Recall details
- Recalling firm
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Quantity
- 92,600 vials
- Distribution
- Nationwide within in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 16, 2026
Related products
- Naropin – drug information
- NDC 63323-285 Naropin · Ropivacaine Hydrochloride 2 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-288 Naropin · Ropivacaine Hydrochloride 10 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-287 Naropin · Ropivacaine Hydrochloride 7.5 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-286 Naropin · Ropivacaine Hydrochloride 5 mg/mL · Fresenius Kabi USA, LLC